Terms: = Lung cancer AND ACVR2A, ACVR2, 92, ENSG00000121989, ACTRII, P27037
7584 results:
1. Contrast-enhanced Imaging in Peripheral Pulmonary Lesions: The Role in US-guided Biopsies.
Wang XY; Yuan ZF; Gan KH; Zhong Y; Huang JX; Huang WJ; Xie YH; Pei XQ
Radiol Cardiothorac Imaging; 2024 Jun; 6(3):e230234. PubMed ID: 38695742
[TBL] [Abstract] [Full Text] [Related]
2. Incidence of thromboembolic events in non-small cell lung cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis.
Yang M; Cao H; Wang C; Yu C; Sun P
J Cancer Res Ther; 2024 Apr; 20(2):509-521. PubMed ID: 38687920
[TBL] [Abstract] [Full Text] [Related]
3. A highly sensitive ratiometric fluorescent probe for detecting HSO
Liu FT; Zhai SM; Gao DF; Yang SH; Zhao BX; Lin ZM
Anal Chim Acta; 2024 May; 1305():342588. PubMed ID: 38677842
[TBL] [Abstract] [Full Text] [Related]
4. Correlation between changes in nutritional status and tumor response in patients receiving immunotherapy for lung cancer (NUTIMMUNO study).
Mahé M; Seegers V; Vansteene D
Support Care Cancer; 2024 Apr; 32(5):312. PubMed ID: 38676729
[TBL] [Abstract] [Full Text] [Related]
5. Non-small cell lung cancer and immune checkpoint inhibitor therapy: does non-alcoholic fatty liver disease have an effect?
Li Y; Gong B; Guo Y; Liu W; Chen C; Jiang S; Pan F; Song J; Yang L; Zhou G
BMC Cancer; 2024 Apr; 24(1):535. PubMed ID: 38671373
[TBL] [Abstract] [Full Text] [Related]
6. Impact of Anti-angiogenic Drugs on Severity of COVID-19 in Patients with Non-Small Cell lung cancer.
Peng S; Huang H; Chen J; Ding X; Zhu X; Liu Y; Chen L; Lu Z
Technol Cancer Res Treat; 2024; 23():15330338241248573. PubMed ID: 38656242
[No Abstract] [Full Text] [Related]
7. Tumor-agnostic transcriptome-based classifier identifies spatial infiltration patterns of CD8+T cells in the tumor microenvironment and predicts clinical outcome in early-phase and late-phase clinical trials.
Roller A; Davydov II; Schwalie PC; Serrano-Serrano ML; Heller A; Staedler N; Ferreira CS; Dietmann G; Klaman I; Valdeolivas A; Korski K; Cannarile MA
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38649280
[TBL] [Abstract] [Full Text] [Related]
8. [Exploration and validation of optimal cut-off values for tPSA and fPSA/tPSA screening of prostate cancer at different ages].
Liu XM; Duan HY; Zhang DQ; Chen C; Ji YT; Zhang YM; Feng ZW; Liu Y; Li JJ; Zhang Y; Li CY; Zhang YC; Yang L; Lyu ZY; Song FF; Song FJ; Huang YB
Zhonghua Zhong Liu Za Zhi; 2024 Apr; 46(4):354-364. PubMed ID: 38644271
[No Abstract] [Full Text] [Related]
9. [cancer survival analysis in Tianjin, 2010 to 2016].
Wang C; Shen CF; Xun LN; Zhang S; Zhang H; Zheng WL; Wang DZ
Zhonghua Zhong Liu Za Zhi; 2024 Apr; 46(4):319-325. PubMed ID: 38644267
[No Abstract] [Full Text] [Related]
10. [Long-term outcome of patients with rectal cancer who achieve complete or near complete clinical responses after neoadjuvant therapy: a multicenter registry study of data from the Chinese Watch and Wait Database].
Zhao YM; Wang WH; Zhang W; Wang L; Li S; Wang JW; Liao LE; Yu GY; Sun Z; Qu YL; Gong Y; Lu Y; Wu T; Li YF; Wang Q; Zhao GH; Xiao Y; Ding PR; Zhang Z; Wu AW
Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Apr; 27(4):372-382. PubMed ID: 38644243
[No Abstract] [Full Text] [Related]
11. Enhanced recovery after surgery program focusing on chest tube management improves surgical recovery after video-assisted thoracoscopic surgery.
Yang D; Zheng X
J Cardiothorac Surg; 2024 Apr; 19(1):253. PubMed ID: 38643197
[TBL] [Abstract] [Full Text] [Related]
12. Comorbidities affecting re-admission and survival in COVID-19: Application of joint frailty model.
Yazdani A; Mozaffarpur SA; Ebrahimi P; Shirafkan H; Mehdinejad H
PLoS One; 2024; 19(4):e0301209. PubMed ID: 38635839
[TBL] [Abstract] [Full Text] [Related]
13. Diagnostic Performance of MRI for the Detection of Pulmonary Nodules: A Systematic Review and Meta-Analysis.
Cavion CC; Altmayer S; Forte GC; Feijó Andrade RG; Hochhegger DQDR; Zaguini Francisco M; Camargo C; Patel P; Hochhegger B
Radiol Cardiothorac Imaging; 2024 Apr; 6(2):e230241. PubMed ID: 38634743
[TBL] [Abstract] [Full Text] [Related]
14. Target proteins-regulated DNA nanomachine-electroactive substance complexes enable separation-free electrochemical detection of clinical exosome.
Zeng X; Wu C; Xiong Y; Zhan Z; Shen C; Lin F; Zhang J; Chen P
Biosens Bioelectron; 2024 Jul; 256():116273. PubMed ID: 38621341
[TBL] [Abstract] [Full Text] [Related]
15. Design, synthesis, biological assessment and molecular modeling studies of novel imidazothiazole-thiazolidinone hybrids as potential anticancer and anti-inflammatory agents.
Kamboj P; Anjali ; Imtiyaz K; Rizvi MA; Nath V; Kumar V; Husain A; Amir M
Sci Rep; 2024 Apr; 14(1):8457. PubMed ID: 38605072
[TBL] [Abstract] [Full Text] [Related]
16. [Comparison of ultrathin bronchoscopy with conventional bronchoscopy for the diagnostic value of peripheral pulmonary lesions].
Li MY; Chen QX; Lu YJ; Pan WY; Zeng DX; Jiang JH
Zhonghua Jie He He Hu Xi Za Zhi; 2024 Apr; 47(4):332-338. PubMed ID: 38599808
[No Abstract] [Full Text] [Related]
17. Association of the Advanced lung cancer Inflammation Index (ALI) and Gustave Roussy Immune (GRIm) score with immune checkpoint inhibitor efficacy in patients with gastrointestinal and lung cancer.
Jiang H; Li B; Wu M; Wang Q; Li Y
BMC Cancer; 2024 Apr; 24(1):428. PubMed ID: 38589844
[TBL] [Abstract] [Full Text] [Related]
18. Systematic proteome-wide Mendelian randomization using the human plasma proteome to identify therapeutic targets for lung adenocarcinoma.
Zhang L; Xiong Y; Zhang J; Feng Y; Xu A
J Transl Med; 2024 Apr; 22(1):330. PubMed ID: 38576019
[TBL] [Abstract] [Full Text] [Related]
19. Development and Evaluation of a Multisource Approach to Extend Mortality Follow-Up for Older Adults With Advanced cancer Enrolled in Randomized Trials.
Lund JL; Cacciatore J; Tylock R; Su IH; Sharma S; Hinton SP; Smith S; Nowels MA; Chen X; Duberstein PR; Hanson LC; Mohile SG
JCO Clin Cancer Inform; 2024 Apr; 8():e2300183. PubMed ID: 38564692
[TBL] [Abstract] [Full Text] [Related]
20. Comprehensive analysis and validation reveal DEPDC1 as a potential diagnostic biomarker associated with tumor immunity in non-small-cell lung cancer.
Lv M; Li X; Yin Z; Yang H; Zhou B
PLoS One; 2024; 19(4):e0294227. PubMed ID: 38564630
[TBL] [Abstract] [Full Text] [Related]
[Next]
